05 Sep BRIXADI® (buprenorphine) Extended-Release Injection for Subcutaneous Use (CIII) is Now Available in the U.S. for the Treatment of Moderate to Severe Opioid Use Disorder
BRIXADI will be available through a restricted distribution program via the BRIXADI REMS Program and is administered only by a...